Global Gastrointestinal Supply, Demand and Key Producers, 2024-2030

Description

The global Gastrointestinal market size is expected to reach $ 44400 million by 2030, rising at a market growth of 3.2% CAGR during the forecast period (2024-2030).

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.

Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.

In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

This report studies the global Gastrointestinal demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gastrointestinal, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gastrointestinal that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gastrointestinal total market, 2019-2030, (USD Million)
Global Gastrointestinal total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Gastrointestinal total market, key domestic companies and share, (USD Million)
Global Gastrointestinal revenue by player and market share 2019-2024, (USD Million)
Global Gastrointestinal total market by Type, CAGR, 2019-2030, (USD Million)
Global Gastrointestinal total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Gastrointestinal market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo and Boehringer Ingelheim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gastrointestinal market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gastrointestinal Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gastrointestinal Market, Segmentation by Type
    Prescription Gastrointestinal Drug
    OTC Gastrointestinal Drug

Global Gastrointestinal Market, Segmentation by Application
    Chronic Gastritis
    Functional Dyspepsia
    Peptic Ulcer
    Acute Gastroenteritis
    Others

Companies Profiled:
    AstraZenec
    Sanofi
    Bayer
    Pfizer
    GlaxoSmithKline
    Teva
    Zeria（Tillotts）
    Perrigo
    Boehringer Ingelheim
    Purdue Pharma
    C.B. Fleet
    Abbott
    Jiangzhong
    Xian-Janssen

Key Questions Answered
1. How big is the global Gastrointestinal market?
2. What is the demand of the global Gastrointestinal market?
3. What is the year over year growth of the global Gastrointestinal market?
4. What is the total value of the global Gastrointestinal market?
5. Who are the major players in the global Gastrointestinal market?

Table of Contents

1 Supply Summary
    1.1 Gastrointestinal Introduction
    1.2 World Gastrointestinal Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Gastrointestinal Total Market by Region (by Headquarter Location)
        1.3.1 World Gastrointestinal Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Gastrointestinal Market Size (2019-2030)
        1.3.3 China Gastrointestinal Market Size (2019-2030)
        1.3.4 Europe Gastrointestinal Market Size (2019-2030)
        1.3.5 Japan Gastrointestinal Market Size (2019-2030)
        1.3.6 South Korea Gastrointestinal Market Size (2019-2030)
        1.3.7 ASEAN Gastrointestinal Market Size (2019-2030)
        1.3.8 India Gastrointestinal Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gastrointestinal Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gastrointestinal Major Market Trends

2 Demand Summary
    2.1 World Gastrointestinal Consumption Value (2019-2030)
    2.2 World Gastrointestinal Consumption Value by Region
        2.2.1 World Gastrointestinal Consumption Value by Region (2019-2024)
        2.2.2 World Gastrointestinal Consumption Value Forecast by Region (2025-2030)
    2.3 United States Gastrointestinal Consumption Value (2019-2030)
    2.4 China Gastrointestinal Consumption Value (2019-2030)
    2.5 Europe Gastrointestinal Consumption Value (2019-2030)
    2.6 Japan Gastrointestinal Consumption Value (2019-2030)
    2.7 South Korea Gastrointestinal Consumption Value (2019-2030)
    2.8 ASEAN Gastrointestinal Consumption Value (2019-2030)
    2.9 India Gastrointestinal Consumption Value (2019-2030)

3 World Gastrointestinal Companies Competitive Analysis
    3.1 World Gastrointestinal Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Gastrointestinal Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Gastrointestinal in 2023
        3.2.3 Global Concentration Ratios (CR8) for Gastrointestinal in 2023
    3.3 Gastrointestinal Company Evaluation Quadrant
    3.4 Gastrointestinal Market: Overall Company Footprint Analysis
        3.4.1 Gastrointestinal Market: Region Footprint
        3.4.2 Gastrointestinal Market: Company Product Type Footprint
        3.4.3 Gastrointestinal Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Gastrointestinal Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Gastrointestinal Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Gastrointestinal Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Gastrointestinal Consumption Value Comparison
        4.2.1 United States VS China: Gastrointestinal Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Gastrointestinal Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Gastrointestinal Companies and Market Share, 2019-2024
        4.3.1 United States Based Gastrointestinal Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Gastrointestinal Revenue, (2019-2024)
    4.4 China Based Companies Gastrointestinal Revenue and Market Share, 2019-2024
        4.4.1 China Based Gastrointestinal Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Gastrointestinal Revenue, (2019-2024)
    4.5 Rest of World Based Gastrointestinal Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Gastrointestinal Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Gastrointestinal Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Gastrointestinal Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Prescription Gastrointestinal Drug
        5.2.2 OTC Gastrointestinal Drug
    5.3 Market Segment by Type
        5.3.1 World Gastrointestinal Market Size by Type (2019-2024)
        5.3.2 World Gastrointestinal Market Size by Type (2025-2030)
        5.3.3 World Gastrointestinal Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Gastrointestinal Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Chronic Gastritis
        6.2.2 Functional Dyspepsia
        6.2.3 Peptic Ulcer
        6.2.4 Acute Gastroenteritis
        6.2.5 Acute Gastroenteritis
    6.3 Market Segment by Application
        6.3.1 World Gastrointestinal Market Size by Application (2019-2024)
        6.3.2 World Gastrointestinal Market Size by Application (2025-2030)
        6.3.3 World Gastrointestinal Market Size by Application (2019-2030)

7 Company Profiles
    7.1 AstraZenec
        7.1.1 AstraZenec Details
        7.1.2 AstraZenec Major Business
        7.1.3 AstraZenec Gastrointestinal Product and Services
        7.1.4 AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 AstraZenec Recent Developments/Updates
        7.1.6 AstraZenec Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Gastrointestinal Product and Services
        7.2.4 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 Bayer
        7.3.1 Bayer Details
        7.3.2 Bayer Major Business
        7.3.3 Bayer Gastrointestinal Product and Services
        7.3.4 Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Bayer Recent Developments/Updates
        7.3.6 Bayer Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Gastrointestinal Product and Services
        7.4.4 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Details
        7.5.2 GlaxoSmithKline Major Business
        7.5.3 GlaxoSmithKline Gastrointestinal Product and Services
        7.5.4 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 GlaxoSmithKline Recent Developments/Updates
        7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.6 Teva
        7.6.1 Teva Details
        7.6.2 Teva Major Business
        7.6.3 Teva Gastrointestinal Product and Services
        7.6.4 Teva Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Teva Recent Developments/Updates
        7.6.6 Teva Competitive Strengths & Weaknesses
    7.7 Zeria（Tillotts）
        7.7.1 Zeria（Tillotts） Details
        7.7.2 Zeria（Tillotts） Major Business
        7.7.3 Zeria（Tillotts） Gastrointestinal Product and Services
        7.7.4 Zeria（Tillotts） Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Zeria（Tillotts） Recent Developments/Updates
        7.7.6 Zeria（Tillotts） Competitive Strengths & Weaknesses
    7.8 Perrigo
        7.8.1 Perrigo Details
        7.8.2 Perrigo Major Business
        7.8.3 Perrigo Gastrointestinal Product and Services
        7.8.4 Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Perrigo Recent Developments/Updates
        7.8.6 Perrigo Competitive Strengths & Weaknesses
    7.9 Boehringer Ingelheim
        7.9.1 Boehringer Ingelheim Details
        7.9.2 Boehringer Ingelheim Major Business
        7.9.3 Boehringer Ingelheim Gastrointestinal Product and Services
        7.9.4 Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Boehringer Ingelheim Recent Developments/Updates
        7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.10 Purdue Pharma
        7.10.1 Purdue Pharma Details
        7.10.2 Purdue Pharma Major Business
        7.10.3 Purdue Pharma Gastrointestinal Product and Services
        7.10.4 Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Purdue Pharma Recent Developments/Updates
        7.10.6 Purdue Pharma Competitive Strengths & Weaknesses
    7.11 C.B. Fleet
        7.11.1 C.B. Fleet Details
        7.11.2 C.B. Fleet Major Business
        7.11.3 C.B. Fleet Gastrointestinal Product and Services
        7.11.4 C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 C.B. Fleet Recent Developments/Updates
        7.11.6 C.B. Fleet Competitive Strengths & Weaknesses
    7.12 Abbott
        7.12.1 Abbott Details
        7.12.2 Abbott Major Business
        7.12.3 Abbott Gastrointestinal Product and Services
        7.12.4 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Abbott Recent Developments/Updates
        7.12.6 Abbott Competitive Strengths & Weaknesses
    7.13 Jiangzhong
        7.13.1 Jiangzhong Details
        7.13.2 Jiangzhong Major Business
        7.13.3 Jiangzhong Gastrointestinal Product and Services
        7.13.4 Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Jiangzhong Recent Developments/Updates
        7.13.6 Jiangzhong Competitive Strengths & Weaknesses
    7.14 Xian-Janssen
        7.14.1 Xian-Janssen Details
        7.14.2 Xian-Janssen Major Business
        7.14.3 Xian-Janssen Gastrointestinal Product and Services
        7.14.4 Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Xian-Janssen Recent Developments/Updates
        7.14.6 Xian-Janssen Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gastrointestinal Industry Chain
    8.2 Gastrointestinal Upstream Analysis
    8.3 Gastrointestinal Midstream Analysis
    8.4 Gastrointestinal Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gastrointestinal Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Gastrointestinal Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Gastrointestinal Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Gastrointestinal Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Gastrointestinal Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Gastrointestinal Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Gastrointestinal Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Gastrointestinal Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Gastrointestinal Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Gastrointestinal Players in 2023
    Table 12. World Gastrointestinal Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Gastrointestinal Company Evaluation Quadrant
    Table 14. Head Office of Key Gastrointestinal Player
    Table 15. Gastrointestinal Market: Company Product Type Footprint
    Table 16. Gastrointestinal Market: Company Product Application Footprint
    Table 17. Gastrointestinal Mergers & Acquisitions Activity
    Table 18. United States VS China Gastrointestinal Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Gastrointestinal Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Gastrointestinal Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Gastrointestinal Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Gastrointestinal Revenue Market Share (2019-2024)
    Table 23. China Based Gastrointestinal Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Gastrointestinal Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Gastrointestinal Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Gastrointestinal Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Gastrointestinal Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Gastrointestinal Revenue Market Share (2019-2024)
    Table 29. World Gastrointestinal Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Gastrointestinal Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Gastrointestinal Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Gastrointestinal Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Gastrointestinal Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Gastrointestinal Market Size by Application (2025-2030) & (USD Million)
    Table 35. AstraZenec Basic Information, Area Served and Competitors
    Table 36. AstraZenec Major Business
    Table 37. AstraZenec Gastrointestinal Product and Services
    Table 38. AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. AstraZenec Recent Developments/Updates
    Table 40. AstraZenec Competitive Strengths & Weaknesses
    Table 41. Sanofi Basic Information, Area Served and Competitors
    Table 42. Sanofi Major Business
    Table 43. Sanofi Gastrointestinal Product and Services
    Table 44. Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Sanofi Recent Developments/Updates
    Table 46. Sanofi Competitive Strengths & Weaknesses
    Table 47. Bayer Basic Information, Area Served and Competitors
    Table 48. Bayer Major Business
    Table 49. Bayer Gastrointestinal Product and Services
    Table 50. Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Bayer Recent Developments/Updates
    Table 52. Bayer Competitive Strengths & Weaknesses
    Table 53. Pfizer Basic Information, Area Served and Competitors
    Table 54. Pfizer Major Business
    Table 55. Pfizer Gastrointestinal Product and Services
    Table 56. Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Pfizer Recent Developments/Updates
    Table 58. Pfizer Competitive Strengths & Weaknesses
    Table 59. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 60. GlaxoSmithKline Major Business
    Table 61. GlaxoSmithKline Gastrointestinal Product and Services
    Table 62. GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. GlaxoSmithKline Recent Developments/Updates
    Table 64. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 65. Teva Basic Information, Area Served and Competitors
    Table 66. Teva Major Business
    Table 67. Teva Gastrointestinal Product and Services
    Table 68. Teva Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Teva Recent Developments/Updates
    Table 70. Teva Competitive Strengths & Weaknesses
    Table 71. Zeria（Tillotts） Basic Information, Area Served and Competitors
    Table 72. Zeria（Tillotts） Major Business
    Table 73. Zeria（Tillotts） Gastrointestinal Product and Services
    Table 74. Zeria（Tillotts） Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Zeria（Tillotts） Recent Developments/Updates
    Table 76. Zeria（Tillotts） Competitive Strengths & Weaknesses
    Table 77. Perrigo Basic Information, Area Served and Competitors
    Table 78. Perrigo Major Business
    Table 79. Perrigo Gastrointestinal Product and Services
    Table 80. Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Perrigo Recent Developments/Updates
    Table 82. Perrigo Competitive Strengths & Weaknesses
    Table 83. Boehringer Ingelheim Basic Information, Area Served and Competitors
    Table 84. Boehringer Ingelheim Major Business
    Table 85. Boehringer Ingelheim Gastrointestinal Product and Services
    Table 86. Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Boehringer Ingelheim Recent Developments/Updates
    Table 88. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 89. Purdue Pharma Basic Information, Area Served and Competitors
    Table 90. Purdue Pharma Major Business
    Table 91. Purdue Pharma Gastrointestinal Product and Services
    Table 92. Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Purdue Pharma Recent Developments/Updates
    Table 94. Purdue Pharma Competitive Strengths & Weaknesses
    Table 95. C.B. Fleet Basic Information, Area Served and Competitors
    Table 96. C.B. Fleet Major Business
    Table 97. C.B. Fleet Gastrointestinal Product and Services
    Table 98. C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. C.B. Fleet Recent Developments/Updates
    Table 100. C.B. Fleet Competitive Strengths & Weaknesses
    Table 101. Abbott Basic Information, Area Served and Competitors
    Table 102. Abbott Major Business
    Table 103. Abbott Gastrointestinal Product and Services
    Table 104. Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Abbott Recent Developments/Updates
    Table 106. Abbott Competitive Strengths & Weaknesses
    Table 107. Jiangzhong Basic Information, Area Served and Competitors
    Table 108. Jiangzhong Major Business
    Table 109. Jiangzhong Gastrointestinal Product and Services
    Table 110. Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Jiangzhong Recent Developments/Updates
    Table 112. Xian-Janssen Basic Information, Area Served and Competitors
    Table 113. Xian-Janssen Major Business
    Table 114. Xian-Janssen Gastrointestinal Product and Services
    Table 115. Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Gastrointestinal Upstream (Raw Materials)
    Table 117. Gastrointestinal Typical Customers
List of Figure
    Figure 1. Gastrointestinal Picture
    Figure 2. World Gastrointestinal Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Gastrointestinal Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Gastrointestinal Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Gastrointestinal Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Gastrointestinal Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Gastrointestinal Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Gastrointestinal Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Gastrointestinal Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Gastrointestinal Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Gastrointestinal Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Gastrointestinal Revenue (2019-2030) & (USD Million)
    Figure 13. Gastrointestinal Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Gastrointestinal Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Gastrointestinal by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Gastrointestinal Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Gastrointestinal Markets in 2023
    Figure 27. United States VS China: Gastrointestinal Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Gastrointestinal Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Gastrointestinal Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Gastrointestinal Market Size Market Share by Type in 2023
    Figure 31. Prescription Gastrointestinal Drug
    Figure 32. OTC Gastrointestinal Drug
    Figure 33. World Gastrointestinal Market Size Market Share by Type (2019-2030)
    Figure 34. World Gastrointestinal Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Gastrointestinal Market Size Market Share by Application in 2023
    Figure 36. Chronic Gastritis
    Figure 37. Functional Dyspepsia
    Figure 38. Peptic Ulcer
    Figure 39. Acute Gastroenteritis
    Figure 40. Others
    Figure 41. Gastrointestinal Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen